Related Experiment Video
Updated: Apr 12, 2026

A Rat Carotid Artery Pressure-Controlled Segmental Balloon Injury with Periadventitial Therapeutic Application
Published on: July 9, 2020
Initial experience with therapeutic geometric modification of the carotid bulb for true resistant hypertension
Najibullah Habib1, Bakhtawar K Mahmoodi, Willem Jan W Bos
1Department of Cardiology, St. Antonius Hospital, Nieuwegein, The Netherlands.
Abstract:
The contribution of carotid baroreceptor feedback in preventing or potentially contributing to the essential hypertensive cascade is poorly understood. It is clear the carotid sinus nerve action potentials are triggered by carotid bulb stretch rather than pressure and are only sustained during pulsatile increases in pressure. In addition, the carotid baroreceptor negative feedback is gradually extinguished in hypertension patients (a phenomenon known as "resetting"). We report a case of significant reduction in blood pressure in a patient with true resistant hypertension after change in the carotid bulb pulsatile strain patterns following the implant of an intravascular prosthesis.
Insights
Carotid baroreceptor feedback
Area of Science:
- Cardiovascular physiology
- Hypertension research
Background:
- Carotid baroreceptor feedback's role in essential hypertension is unclear.
- Carotid sinus nerve potentials depend on bulb stretch and pulsatile pressure.
- Baroreceptor feedback resets in hypertensive patients.
Observation:
- A resistant hypertension patient received an intravascular prosthesis.
- The prosthesis altered carotid bulb pulsatile strain patterns.
Findings:
- The patient experienced a significant blood pressure reduction.
- This suggests a link between altered pulsatile strain and blood pressure control.
Implications:
- Modulating carotid bulb strain may offer new hypertension treatments.
- Further research into baroreceptor mechanics is warranted.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Aortic Regurgitation III: Medical Management

